Light Sciences Oncology, Inc. is developing Light Infusion Therapy to provide safer and more effective treatment to cancer patients.
Location: United States, Washington, Bellevue
Employees: 11-50
Total raised: $15M
Founded date: 1994
Investors 2
| Date | Name | Website |
| 14.05.2021 | EW Healthc... | ewhealthca... |
| - | Hercules C... | htgc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.05.2007 | - | $15M | - |
Mentions in press and media 7
| Date | Title | Description |
| 22.11.2010 | Light Sciences Oncology CEO Exits for New Job; Company Still Waiting for Pivotal Results | Share Share on Facebook Share on Twitter LinkedIn Email Reprints The CEO of Light Sciences Oncology, the Bellevue, WA-based company developing a first-of-its-kind drug/device combo therapy for cancer, has left to take a new job running anot... |
| 18.05.2009 | Bionavitas Pursues Algae Dream in Food Additives, Toxic Cleanup—Then Maybe Biofuel | Share Share on Facebook Share on Twitter LinkedIn Email Reprints When most entrepreneurs think of algae, they think of its potential to churn out renewable biofuels. But Bionavitas wants you to think first about dietary supplements. It also... |
| 30.03.2009 | Essex Woodlands raises almost $1B for life science investments | Essex Woodlands Health Ventures announced today that it brought in $900 million for its eighth fund, one of the largest sums ever raised by a health care-focused venture firm, according to the Wall Street Journal — even more impressive cons... |
| 11.02.2008 | Life sciences briefing: Monday, Feb. 11, 2008 | TODAY’S HEADLINES: PolyRemedy, developer of robotic wound care, takes in $25M (release) Bacchus Vascular gets $15M for clot-busting device (VentureWire) Protein-evolution company Modular Genetics gets $1.2M (VentureWire) PharmatrophiX gets ... |
| 07.02.2008 | IPO roundup: Is the window slamming on life sciences? | It’s sure starting to look that way. News that Archemix, a Cambridge, Mass., developer of aptamer-based drugs, yesterday withdrew its $72.5 million IPO follows closely on the heels of several other recent several other IPO collapses, includ... |
| 11.07.2007 | IPO still on hold, Light Sciences beams up $30M | Snoqualmie, Wash.-based Light Sciences Oncology, a developer of light-activated cancer drugs, raised $30 million in a second funding round, even though it still has an IPO registration on file with the SEC. The latest funding closes out the... |
| 18.05.2007 | Light Sciences Oncology, IPO on hold, raises $15M | Light Sciences Oncology, a Snoqualmie, Wash., developer of light-activated cancer drugs and delivery systems, raised $15 million in a second venture round despite having an IPO on file with the SEC, VentureWire reports (subscription require... |